This document discusses male infertility caused by poor sperm motility or asthenospermia. It defines asthenospermia as less than 40% sperm motility or less than 32% with progressive motility. Poor sperm motility can be caused by damage to the testicles from infections, injuries, varicocele, or drug/steroid use. Diagnosis involves semen analysis to assess sperm count, morphology, and motility. Lifestyle changes like reducing heat exposure, smoking, drugs, and weight can help improve motility. Treatments may include supplements, surgery to address issues like varicocele, or assisted reproduction techniques.
In this presentation we talk about the current management of male infertility in Delhi India.
Dr Vijayant Gupta is male infertility expert in new Delhi India
We talk about
1. Non obstructive azoospermia
2. Obstructive azoospermia
3. Oligospermia
http://drvijayantgovinda.com/male-infertility-treatment-in-delhi-male-infertility-specialist/
http://drvijayantgovinda.com/male-infertility-treatment-in-delhi-male-infertility-specialist/azoospermia-treatment-in-delhi-nil-sperm-count/
Physiology of Male Infertility | Seeds of InnocenceSOI Delhi
Male Infertility is a inability that causes pregnancy in a female fertile. Male infertility is commonly due to Low sperm Count. Soi provides best male infertility treatment in delhi, ghaziabad - India. Call us : 9810350512
visit : www.seedsofinnocence.com
Treatment of Male infertility:-Emphasis on enhnacing Sperm count: New Natural...VISHAL CHANDRA
Oligospermia is a Medical problem commonly known as 'MALE INFERTILITY' and is signified by deficit in Sperm count due to which the female partner shows inability to conceive.
A new Herbal Medicine has been clinically researched & developed for treatment of OLIGOSPERMIA.
The clinical trial has been indexed by World Health Organization ( WHO) Clinical registry platform.
The research & development has been done by an Indian pharmaceutical MNC- TULIP LAB PVT. LTD.
The company has modern research center and Internationally accredited Manufacturing facility and has Pharmaceutical Products & Clinically researched Herbal Medicines/supplements.
For OUT LICENSING /CONTRACT MANUFACTURING, connect with :
Mr. VISHAL CHANDRA (GENERAL MANAGER-INTERNATIONAL BUSINESS):
* e-mail: vishalvns04@yahoo.co.in
* Skype: vishalukraine
Male Infertility Review 2011 By Paul J. Turek MD FACS, FRSM, Director of The ...The Turek Clinics
Lecture written and presented by Paul J. Turek MD FACS, FRSM. Dr. Turek is the Director of the The Turek Clinic in San Francisco and Former Professor and Endowed Chair at the University of California San Francisco (UCSF).
Newer Modalities for Semen Testing | Male Infertility | Seeds Of InnocenceSOI Delhi
Male Infertility is a inability that causes pregnancy in a female fertile. Male infertility is commonly due to Low sperm Count. Soi provides best male infertility treatment in delhi, ghaziabad - India. For more information call us 9810350512
Mild To Severe Oligospermia Oligozoospermia is a condition where the sperm count in male is of low count which is a major cause for male infertility. Oligozoospermia refers to semen with a low concentration of sperm and is a common finding in male infertility.Often semen with a decreased sperm concentration may also show significant abnormalities in sperm morphology and motility (technically “oligoasthenoteratozoospermia”).
REPRODUCTIVE ISSUES DUE TO LOW SPERM COUNT.
DIAGNOSIS, TREATMENT, MANAGEMENT AND PREVENTION.
For Scientific Free Lectures, Visit - http://bit.ly/VisitZofirAcademy
In this presentation we talk about the current management of male infertility in Delhi India.
Dr Vijayant Gupta is male infertility expert in new Delhi India
We talk about
1. Non obstructive azoospermia
2. Obstructive azoospermia
3. Oligospermia
http://drvijayantgovinda.com/male-infertility-treatment-in-delhi-male-infertility-specialist/
http://drvijayantgovinda.com/male-infertility-treatment-in-delhi-male-infertility-specialist/azoospermia-treatment-in-delhi-nil-sperm-count/
Physiology of Male Infertility | Seeds of InnocenceSOI Delhi
Male Infertility is a inability that causes pregnancy in a female fertile. Male infertility is commonly due to Low sperm Count. Soi provides best male infertility treatment in delhi, ghaziabad - India. Call us : 9810350512
visit : www.seedsofinnocence.com
Treatment of Male infertility:-Emphasis on enhnacing Sperm count: New Natural...VISHAL CHANDRA
Oligospermia is a Medical problem commonly known as 'MALE INFERTILITY' and is signified by deficit in Sperm count due to which the female partner shows inability to conceive.
A new Herbal Medicine has been clinically researched & developed for treatment of OLIGOSPERMIA.
The clinical trial has been indexed by World Health Organization ( WHO) Clinical registry platform.
The research & development has been done by an Indian pharmaceutical MNC- TULIP LAB PVT. LTD.
The company has modern research center and Internationally accredited Manufacturing facility and has Pharmaceutical Products & Clinically researched Herbal Medicines/supplements.
For OUT LICENSING /CONTRACT MANUFACTURING, connect with :
Mr. VISHAL CHANDRA (GENERAL MANAGER-INTERNATIONAL BUSINESS):
* e-mail: vishalvns04@yahoo.co.in
* Skype: vishalukraine
Male Infertility Review 2011 By Paul J. Turek MD FACS, FRSM, Director of The ...The Turek Clinics
Lecture written and presented by Paul J. Turek MD FACS, FRSM. Dr. Turek is the Director of the The Turek Clinic in San Francisco and Former Professor and Endowed Chair at the University of California San Francisco (UCSF).
Newer Modalities for Semen Testing | Male Infertility | Seeds Of InnocenceSOI Delhi
Male Infertility is a inability that causes pregnancy in a female fertile. Male infertility is commonly due to Low sperm Count. Soi provides best male infertility treatment in delhi, ghaziabad - India. For more information call us 9810350512
Mild To Severe Oligospermia Oligozoospermia is a condition where the sperm count in male is of low count which is a major cause for male infertility. Oligozoospermia refers to semen with a low concentration of sperm and is a common finding in male infertility.Often semen with a decreased sperm concentration may also show significant abnormalities in sperm morphology and motility (technically “oligoasthenoteratozoospermia”).
REPRODUCTIVE ISSUES DUE TO LOW SPERM COUNT.
DIAGNOSIS, TREATMENT, MANAGEMENT AND PREVENTION.
For Scientific Free Lectures, Visit - http://bit.ly/VisitZofirAcademy
We provide complete treatment of infertility in Indore at a very low cost. We have a team of very experienced IVF Specialist doctors, who have been providing treatment to childless couples for many years. If you are looking for a Fertility centre in Indore as per your budget, then you should visit the Care Womens Centre. Book an appointment today with the bsst IVF center in indore, call now 8889016663 and visit https://www.carewomenscentre.com/ for more information.
Infertility problem and Fertility managementRotunda TCHR
Infertility India, Infertility Clinic India, Infertility Surgery India, Infertility, Infertility treatment India, Infertility abroad, conceive a baby, IVF, ICSI, PGD, GIFT, ZIFT, egg donation, sperm, embryo transfer, Pregnancy, egg donor, low cost IVF treatment, diagnosis, female fertility, male infertility, infertility specialist, infertility specialist in India, infertility treatment hospitals in India, infertility treatment clinic India, infertility treatment centre India, test tube baby, gender selection, sex selection, assisted reproductive technique, causes of infertility, procedure of fertility, IVF clinic, IVF clinics in India, pregnancy, sperm analysis, low sperm count, infertility treatment, infertility causes, infertility,IVF India, IVF Clinic India, IVF India, IVF Centre, IVF Treatment India, IVF, IVF Clinic, IVF Center, IVF India, IVF Specialist Doctor, IVF Treatment, IVF Treatment In India, IVF Treatment In Abroad, Women Infertility, Men Fertility, Test Tube Baby, IVF Procedure, ICSI, Embryo Transfer, Variations On Embryo Transfer, GIFT, ART, Egg Donation, Egg Donor, Low Cost Of Treatment, IVF Treatment Available In India, IVF,IVF India, IVF Clinic, Egg Donation, Surrogacy India, Fertility, Infertility, Surrogacy, Genetic Treatment, Human Reproduction, IVF Specialists, Success Rate, Fertility In India, Fertility Abroad, Fertility Treatment In India, Fertility Treatment In Abroad, Infertility In India, Infertility Treatment Abroad, Infertility Treatment In India, Infertility Treatment Abroad, IVF Treatment, IVF Treatment In India, IVF Treatment Abroad, Surrogacy, Surrogacy Treatment, Surrogacy Treatment In India, Surrogacy Treatment In Abroad, Gynecologist, Surrogate Mother, Surrogate Motherhood, Surrogate Mother India, Ovulation Induction, Laser Assisted Hatching, Oocyte Retrieval
I Want to Be a Father But My Sperm Count is Too Low!Online
My wife and I had been trying to get pregnant for over a year. We decided to get checked out and they found I was the one with the problem. They said my sperm count was low and I would need treatment.
Infertility in male and female.pptx for Nursing studentsankitarya2550
Infertility is a condition referred to unavailability to conceive after continue one year of regular coitus without using any kind of contraceptive and family planning methodology.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
2. failure of conception after at least 12 months of unprotected
intercourse
chance of a normal couple conceiving is estimated at 20-25% per
month, 75% by 6 months and 90% at 1 year
Epidemiology:
50% is due to male factor
25% of couples may be affected at some point in their reproductive
years
3. Pathophysiology:
failure of fertilization of the normal ovum due to
defective sperm development, function or inadequate
numbers.
abnormality of morphology (teratospermia)
low sperm number (oligospermai)
abnormality of motility (asthenospermia)
absent sperm (azoospermia)
5. Sperm motility is the ability of sperm to move efficiently. This is
important in fertility because sperm need to move through the
woman's reproductive tract to reach and fertilize her egg. Poor
sperm motility can be a cause of male factor infertility.
Healthy sperm motility is defined as sperm with forward
progressions of at least 25 micrometers per second. If a man has
poor sperm mobility, it’s called asthenospermia or
asthenozoospermia.
defined as <40% sperm motility or less than 32% with
6. There are two kinds of sperm motility:
Progressive motility: refers to sperm that are swimming in
a mostly straight line or large circles.
Non-progressive motility: refers to sperm that do not
travel in straight lines or that swim in very tight circles
For the sperm to get through the cervical mucus to fertilize a
woman's egg, they need to have progressive motility of at
least 25 micrometers a second.
Poor sperm motility or asthenozoospermia is diagnosed
when less than 32 percent of the sperm are able to move
efficiently.
7. How does it affect fertility?
Worldwide, around 60 to 80 million couples are affected by infertility, and the
rates vary from country to country.
In the United States, the rate is thought to be around 10 percent of couples. The
figure is based on the definition of infertility as the inability to conceive after 12
months of trying.
Male factor infertility is when an issue with the man's biology makes him unable
to impregnate a woman. It accounts for between 40 to 50 percent of infertility
cases and affects around 7 percent of men.
Male infertility is usually the result of deficiencies in the semen, the most common
of which are:
low sperm count or oligospermia
poor sperm motility
abnormal sperm shape or teratospermia
Around 90 percent of male infertility issues are caused by low sperm count, but
poor sperm motility is an important factor also.
8. Causes of low motility
The causes of low sperm motility vary, and many cases are unexplained.
Damage to the testicles, which make and store sperm, can impact on the quality
of sperm.
Common causes of testicle damage include:
Infection
testicular cancer
testicular surgery
an issue a man is born with undescended testicles
Injury
The long-term use of anabolic steroids can reduce sperm count and
motility.
Drugs, such as cannabis and cocaine, as well as some herbal remedies,
can also affect semen quality.
Varicocele, a condition of enlarged veins in the scrotum, has also been
associated with low sperm motility.
9. Diagnosis:
Semen analysis is the most basic and useful test, and it can
detect 9 out of 10 men with a fertility problem. The test assesses
the formation of the sperm, as well as how they interact in the
seminal fluid.
The sample is usually collected by masturbation. The man
will be asked to abstain from sex for between 2 and 7 days
before collecting the sample to increase the volume of semen.
It is necessary for the whole ejaculation is be collected in a
sterile container to ensure the test results are complete.
The sample is usually collected in a private room at the
doctor's office or collection facility, though in some
circumstances it can be produced at home. If this is the case,
the sample will need to be delivered for analysis within an
hour.
10. The sample should not be stored in the fridge, and doctors
recommend holding it close to the body during transportation
to keep it at body temperature. This will ensure it is the best
possible quality when it is analyzed.
Sometimes, the sample can be collected via sexual
intercourse, either in a specially designed condom or by
withdrawing before ejaculation. It is important not to use a
commercial condom for this, as many have lubricants or
spermicides that can taint the sample.
Samples can vary for different reasons, including the length
of abstinence from sexual intercourse and illness. As a result,
two samples are usually collected. They may be anywhere
from 2 to 4 weeks apart.
If the percentage of progressively motile sperm is less than
32 percent, the diagnosis may be poor sperm motility.
11. How to improve sperm motility?
There are lifestyle choices people can make that will help improve
the quality of their sperm. Smoking can reduce fertility and has
been shown to affect sperm motility.
Recreational drugs, including cannabis, amphetamines, and
opiates, and excessive alcohol consumption also reduce sperm
quality. Doctors advise people to avoid these if they are trying to
conceive.
Being overweight with a body mass index of 25 or more can affect
both the quality and quantity of sperm.
There is a link between an increased temperature of the scrotum
and a reduction in the quality of sperm. The ideal, sperm-
producing temperature is around 94 °F, or just below body
temperature, so loose-fitting underwear and taking simple
measures to keep the testicles cool may help.
12. Treatment
Poor sperm motility can lead to male infertility, but treatments are
available.
Some lifestyle changes may help increase sperm motility
for some men:
exercise regularly,
maintain a healthy weight
limit cell phone exposure
reduce alcohol
quit smoking
Some supplements may also help improve sperm
motility:
Selenium (200mg) with vitamin E (400unit),
13. Surgical interventions to be considered include the following:
Varicocelectomy,
Vasovasostomy or vasoepididymostomy
Transurethral resection of the ejaculatory ducts
Sperm retrieval techniques
Electroejaculation
Artificial insemination
Assisted reproduction techniques
In vitro fertilization
Gamete intrafallopian transfer (GIFT) and zygote intrafallopian
transfer (ZIFT)
Intracytoplasmic sperm injectio
15. Azoospermia is defined as the absence of sperm in the ejaculation and is
identified in 1% of all men and up to 10% to 15% on infertile males.
Aspermia is defined as a complete absence of seminal fluid
during orgasm.
The initial diagnosis of azoospermia is made when no spermatozoa can be
detected on high-powered microscopic examination of centrifuged seminal fluid
on at least two occasions.
Etiology:
Obstructive
absent or obstructed vas deferens, epididymal or ejaculatory duct
obstruction related to infection or cystic fibrosis
Non-obstructive
hypogonadotrophism (Kallmann’s syndrome, pituitaru tumor)
abnormalities of spermatogenesis (chromosomal abnormalities, toxins,
idiopathic, varicocoele, testicular torsion
17. Defects in any of the ducts involved in the sperm delivery system
such as:
1. Epididymis,
2. Vas Deferens,
3. Ampulla of vas, and
4. Ejaculatory duct.
Ductal obstruction
Congenital (you were born with it)
Acquired (idiopathic)
Vasectomy
most common cause
Infection
Infection can make
a scar form in epididymis
18. Diagnosis
Medical History:
Childhood illness : orchitis or cryptorchidism
Genital trauma,
Prior pelvic/inguinal surgery,
Infection,
Gonadotoxin exposure: prior radiation, chemotherapy,
Current medical therapy,
Family history of birth defects,
Mental retardation,
Reproductive failure,
Cystic fibrosis
Physical Examination:
Testis size and consistency (normal testis
volume > 19 ML),
Consistency of epididymis,
Secondary sex characteristics,
Presence and consistency of the vasa
deferentia,
Presence of varicocele,
Masses upon digital rectal examination.
19. Hormone assay:
raised FSH indicates non-obstructive cause ,
normal FSH with normal testes indicates obstruction
Chromosomal analysis:
Used to exclude Kleinfelter’s syndrome in patient presenting with
azoospermia, small soft testes, gynecomastia, elevated FSH/LH and low
testosterone.
Testicular biopsy:
performed to assess if normal sperm maturation is occurring,
for sperm retrieval for later therapeutic use
Trans-rectal ultrasound scan:
performed to assess absence or blockage of vas deferens and ejaculatory duct
obstruction,
exclude cystic fibrosis in patients with vas deferens defect
20. Management:
Bilateral absence or agenesis of vas deferens:
Microsurgical epididymal sperm aspiration (MESA),
consider artificial insemination using donor (AID),
Primary testicular failure with testicular atrophy:
Testicular sperm extraction (TESE),
in vitro fertilization (IVF),
AID,
Primary testicular failure with normal testes:
TESE, IVF, AID,
Obstructive cause with normal testis:
epididymovasostomy,
vasosostomy